Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · IEX Real-Time Price · USD
0.412
-0.017 (-3.96%)
At close: Jul 19, 2024, 4:00 PM
0.400
-0.012 (-2.84%)
Pre-market: Jul 22, 2024, 8:52 AM EDT
Company Description
Newcourt Acquisition Corp does not have significant operations.
It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Newcourt Acquisition Corp was incorporated in 2021 and is based in Oakland, California. Newcourt Acquisition Corp operates as a subsidiary of Newcourt SPAC Sponsor LLC.
Psyence Biomedical Ltd.
| Country | Ontario, Canada |
| Founded | 1994 |
| Industry | Shell Companies |
| Sector | Financials |
Contact Details
Address: 121 Richmond Street West Penthouse, Suite 1300 Toronto, A6 M5H 2K1 Ontario, Canada | |
| Phone | 27744604171 |
| Website | psyence.com |
Stock Details
| Ticker Symbol | PBM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001985062 |
| ISIN Number | CA74449F1009 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Marc Gregory Balkin | Chief Executive Officer and Director |
| Jurgen Van De Vyver | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 5, 2024 | 6-K | Report of foreign issuer |
| Jun 20, 2024 | 6-K | Report of foreign issuer |
| Jun 6, 2024 | 6-K | Report of foreign issuer |
| May 14, 2024 | EFFECT | Notice of Effectiveness |
| May 10, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| May 8, 2024 | UPLOAD | Filing |
| May 7, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Apr 29, 2024 | UPLOAD | Filing |
| Apr 18, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Mar 15, 2024 | 6-K | Report of foreign issuer |